Skip to main content
OpenTrials
Completed

NCT Number: NCT02678585

Nalbuphine as an Adjuvant to Intravenous Regional Anesthesia

The effect of addition of nalbuphine to lidocaine in intravenous regional anesthesia

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Postoperative Pain Neurologic Manifestations Pain Pain, Postoperative Pathologic Processes Pathological Conditions, Signs and Symptoms Postoperative Complications Signs and Symptoms

Age range

20 year–50 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Assiut university hospital

Asyut, 71515, Egypt

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • adult patients
  • American Society of Anesthesiologists (ASA) physical status I-II
  • age between 20 and 50 years old
  • scheduled for elective unilateral short hand surgery

Exclusion criteria

  • allergy to study medications
  • body mass index > 35 kg/m2
  • patients with sickle cell disease or Reynaud disease
  • patient refusal

Treatment and study plan

Nalbuphine

Drug

53 patients received intravenous regional lidocaine plus nalbuphine

Lidocaine

Drug

53 patients received intravenous regional lidocaine

Primary outcomes

  1. Tourniquet and postoperative pain measured by visual analogue scale

    Time frame: 4 hours

Secondary outcomes

  1. Cortisol level

    Time frame: 4 hours

Sponsors and collaborators

Lead sponsor

Assiut University

Other

Registry information

Important dates

Study start
2015
Primary completion
2016
Study completion
2016
First posted
Feb 10, 2016
Registry last updated
Jun 26, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.